Cytokinetics Earnings
NASDAQ: CYTKHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Next earnings date
Wed, Nov 4, 2026
Fiscal period
Sep/2026
EPS estimate
$-1.52
Cytokinetics earnings summary
Cytokinetics is scheduled to report Sep/2026 earnings on Nov 4, 2026, with analysts expecting EPS of $-1.52. In its most recent report on Aug 6, 2026 (Q2 2026), CYTK posted EPS of $-1.50. Revenue for the quarter was $28.6 million.
Across the last 16 reports, CYTK shares moved an average of 6.6% (in either direction) in the first trading session after results, rising 4 times and falling 12 times.
Summary generated from market data by MetaCap's automated system. Methodology
CYTK earnings history
| Report date | EPS est. | EPS actual | Surprise | Price reaction |
|---|---|---|---|---|
| Aug 6, 2026 | — | $-1.50 | — | -3.4% |
| May 5, 2026 | — | $-1.67 | — | -1.4% |
| Feb 26, 2026 | — | $-1.51 | — | -2.9% |
| Nov 5, 2025 | — | $-2.55 | — | +10.4% |
| Aug 7, 2025 | — | $-1.12 | — | +13.4% |
| May 6, 2025 | — | $-1.36 | — | -2.2% |
| Feb 27, 2025 | — | $-1.26 | — | -5.6% |
| Nov 7, 2024 | — | $-1.36 | — | -13.4% |
| Aug 9, 2024 | — | $-1.31 | — | +1.3% |
| May 10, 2024 | — | $-1.33 | — | -4.1% |
| Feb 28, 2024 | — | $-1.38 | — | -11.1% |
| Nov 3, 2023 | — | $-1.35 | — | -10.5% |
| Aug 3, 2023 | — | $-1.34 | — | -1.3% |
| May 5, 2023 | — | $-1.38 | — | -4.6% |
| Mar 1, 2023 | — | $-1.53 | — | -15.1% |
| Nov 4, 2022 | — | $-1.52 | — | +5.0% |
Surprise compares reported EPS with the consensus estimate. Price reaction is the close-to-close move in the first session after the report. Learn about the earnings surprise.